Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.

This review aims at evaluating the existing evidence regarding post reperfusion syndrome, providing a description of the pathophysiologic mechanisms involved and possible management and preventive strategies. A PubMed search was conducted using the MeSH database, "Reperfusion" AND "liver transplantation" were the combined MeSH headings; EMBASE and the Cochrane library were also searched using the same terms. 52 relevant studies and one ongoing trial were found. The concept of post reperfusion syndrome has evolved through years to a multisystemic disorder. The implications of the main organ, recipient and procedure related factors in the genesis of this complex syndrome are discussed in the text as the novel pharmacologic and technical approaches to reduce its incidence. However the available evidence about risk factors, physiopathology and preventive measures is still confusing, the presence of two main definitions and the numerosity of possible confounding factors greatly complicates the interpretation of the studies.

[1]  Sung-Moon Jeong,et al.  Postreperfusion syndrome during liver transplantation , 2015, Korean journal of anesthesiology.

[2]  Pedro M. Baptista,et al.  Emerging concepts in liver graft preservation. , 2015, World journal of gastroenterology.

[3]  J. Henriksen,et al.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects. , 2014, World journal of gastroenterology.

[4]  E. Caglayan,et al.  Cirrhotic cardiomyopathy: a cardiologist's perspective. , 2014, World journal of gastroenterology.

[5]  Felipe Lobato da Silva Costa,et al.  Combined remote ischemic perconditioning and local postconditioning on liver ischemia-reperfusion injury. , 2014, The Journal of surgical research.

[6]  E. Pretto,et al.  Hemodynamic recovery following postreperfusion syndrome in liver transplantation. , 2014, Journal of cardiothoracic and vascular anesthesia.

[7]  W-C Lee,et al.  Ischemic reperfusion injury-induced oxidative stress and pro-inflammatory mediators in liver transplantation recipients. , 2014, Transplantation proceedings.

[8]  R. Speich,et al.  Inflammatory cytokines in pulmonary hypertension , 2014, Respiratory Research.

[9]  K. Kalimeris,et al.  Global Consequences of Liver Ischemia/Reperfusion Injury , 2014, Oxidative medicine and cellular longevity.

[10]  N. Fayed,et al.  Goal directed preemptive ephedrine attenuates the reperfusion syndrome during adult living donor liver transplantation , 2014 .

[11]  J. García-Valdecasas,et al.  Stroke Volume Response to Liver Graft Reperfusion Stress in Cirrhotic Patients , 2014, World Journal of Surgery.

[12]  L. Harsányi,et al.  Remote ischemic perconditioning protects the liver from ischemia-reperfusion injury. , 2013, The Journal of surgical research.

[13]  T. Hibi,et al.  Crystalloid flush with backward unclamping may decrease post‐reperfusion cardiac arrest and improve short‐term graft function when compared to portal blood flush with forward unclamping during liver transplantation , 2013, Clinical transplantation.

[14]  Hyun Sik Chung,et al.  Effects of magnesium pretreatment on the levels of T helper cytokines and on the severity of reperfusion syndrome in patients undergoing living donor liver transplantation. , 2013, Magnesium research.

[15]  R. Cohen,et al.  Sympathetic withdrawal is associated with hypotension after hepatic reperfusion , 2013, Clinical Autonomic Research.

[16]  A. Mastro,et al.  Association between plasma cyclic guanosine monophosphate levels and hemodynamic instability during liver transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  Hyung‐Chul Lee,et al.  Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  Haitao Xu,et al.  Evaluation of the right ventricular ejection fraction during classic orthotopic liver transplantation without venovenous bypass , 2012, Clinical transplantation.

[19]  H. Kim,et al.  Incidence and predictors of post‐reperfusion syndrome in living donor liver transplantation , 2012, Clinical transplantation.

[20]  Johnny C. Hong,et al.  Regulated hepatic reperfusion mitigates ischemia-reperfusion injury and improves survival after prolonged liver warm ischemia: a pilot study on a novel concept of organ resuscitation in a large animal model. , 2012, Journal of the American College of Surgeons.

[21]  H. Zhang,et al.  Postreperfusion syndrome during orthotopic liver transplantation: a single-center experience. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.

[22]  M. Krawczyk,et al.  The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. , 2011, Annals of transplantation.

[23]  H. Ryu,et al.  Nafamostat Mesilate Attenuates Postreperfusion Syndrome during Liver Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  E. Pretto,et al.  The effect of methylene blue during orthotopic liver transplantation on post reperfusion syndrome and postoperative graft function , 2011, Journal of hepato-biliary-pancreatic sciences.

[25]  A. Güemes,et al.  Celsior Versus University of Wisconsin Preserving Solutions for Liver Transplantation: Postreperfusion Syndrome and Outcome of a 5-Year Prospective Randomized Controlled Study , 2011, World Journal of Surgery.

[26]  A. Mastro,et al.  Release of cytokines and hemodynamic instability during the reperfusion of a liver graft , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  E. Pretto,et al.  Body surface area index predicts outcome in orthotopic liver transplantation , 2011, Journal of hepato-biliary-pancreatic sciences.

[28]  M. A. Sahmeddini,et al.  Hypotension after reperfusion in liver transplantation: histidine-tryptophan-ketoglutarate versus University of Wisconsin solution. , 2010, Progress in transplantation.

[29]  S. Parsa,et al.  Post-reperfusion Syndrome and Outcome Variables after Orthotopic Liver Transplantation , 2010, International journal of organ transplantation medicine.

[30]  E. Bernardi,et al.  Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. , 2010, Transplantation proceedings.

[31]  R. J. Paneque,et al.  Rapid and homogeneous reperfusion as a risk factor for postreperfusion syndrome during orthotopic liver transplantation , 2010 .

[32]  M. Ramsay,et al.  Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictors , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  M. Gwak,et al.  Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. , 2008, Transplantation proceedings.

[34]  J. Bermejo,et al.  Cardiac Dysfunction During Liver Transplantation: Incidence and Preoperative Predictors , 2008, Transplantation.

[35]  A. Marcos,et al.  The impact of postreperfusion syndrome on short‐term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  K. Gurusamy,et al.  Ischaemic preconditioning for liver transplantation. , 2008, The Cochrane database of systematic reviews.

[37]  M. D. de Moura,et al.  Elevated nitric oxide and 3',5' cyclic guanosine monophosphate levels in patients with alcoholic cirrhosis. , 2008, World journal of gastroenterology.

[38]  L. Grande,et al.  Ischemic Pre‐conditioning in Deceased Donor Liver Transplantation: A Prospective Randomized Clinical Trial , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[39]  I. Konstantinov,et al.  Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.

[40]  J. Figueras,et al.  Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: Influence of hepatic artery or portal vein revascularization of the graft , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[41]  G. Ercolani,et al.  Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[42]  B. Gridelli,et al.  Comparison of two different techniques of reperfusion in adult orthotopic liver transplantation , 2006, Clinical transplantation.

[43]  S. Fuggle,et al.  Ischemic Preconditioning of Cadaver Donor Livers Protects Allografts following Transplantation , 2006, Transplantation.

[44]  P. Hayes,et al.  Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites , 2005, Gut.

[45]  H. Bismuth,et al.  Effects of 10 Minutes of Ischemic Preconditioning of the Cadaveric Liver on the Graft's Preservation and Function: The Ying and the Yang , 2005, Annals of surgery.

[46]  J. Skurnick,et al.  Ischemic preconditioning in deceased donor liver transplantation: A prospective randomized clinical trial of safety and efficacy , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[47]  B. Pollwein,et al.  Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. , 2004, British journal of anaesthesia.

[48]  X. Gu,et al.  Effect of cold-ischemia time on nuclear factor-kappaB activation and inflammatory response in graft after orthotopic liver transplantation in rats. , 2004, World journal of gastroenterology.

[49]  M. Bellamy,et al.  Complement membrane attack complex and hemodynamic changes during human orthotopic liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[50]  R. Busuttil,et al.  The utility of marginal donors in liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[51]  Y. Tokat,et al.  Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. , 2003, Transplantation proceedings.

[52]  José A Fernández,et al.  Activation of protein C during reperfusion in clinical liver transplantation , 2003, Transplantation.

[53]  J. Findlay,et al.  Aprotinin reduces vasoactive medication use during adult liver transplantation. , 2003, Journal of clinical anesthesia.

[54]  J. Fung,et al.  Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury12 , 2002, Transplantation.

[55]  M. Bellamy,et al.  The Effect of Methylene Blue on the Hemodynamic Changes During Ischemia Reperfusion Injury in Orthotopic Liver Transplantation , 2002, Anesthesia and analgesia.

[56]  A. Nanashima,et al.  Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. , 2001, Journal of hepato-biliary-pancreatic surgery.

[57]  A. Sheil,et al.  Postreperfusion syndrome in orthotopic liver transplantation. , 2000, Transplantation proceedings.

[58]  E. Jaurrieta,et al.  Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. , 2000 .

[59]  H. Putter,et al.  Reduced Need for Vasopressors in Patients Receiving Aprotinin during Orthotopic Liver Transplantation , 2000, Anesthesiology.

[60]  L. Lindgren,et al.  Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study , 2000, The Lancet.

[61]  P. Parrilla,et al.  Changes in serum potassium during reperfusion in liver transplantation. , 1999, Transplantation proceedings.

[62]  P. Parrilla,et al.  Atropine prophylaxis of the postreperfusion syndrome in liver transplantation. , 1999, Transplantation proceedings.

[63]  P. Parrilla,et al.  Effect of reperfusion on right ventriculoarterial coupling in liver transplantation. , 1999, Transplantation proceedings.

[64]  P. Parrilla,et al.  Influence of surgical technique on postreperfusion syndrome during liver transplantation. , 1999, Transplantation proceedings.

[65]  M. Bellamy,et al.  Changes in inflammatory mediators during orthotopic liver transplantation. , 1997, British journal of anaesthesia.

[66]  M. Csete,et al.  Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation. , 1997, Transplantation.

[67]  M. Vigil,et al.  Response to Clamping of the Inferior Vena Cava as a Factor for Predicting Postreperfusion Syndrome During Liver Transplantation , 1997, Anesthesia and analgesia.

[68]  K. Tan,et al.  Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation. , 1995, British journal of anaesthesia.

[69]  N. Heaton,et al.  Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation. , 1995, British journal of anaesthesia.

[70]  S. Blanot,et al.  Circulating endotoxins and postreperfusion syndrome during orthotopic liver transplantation. , 1995, Transplantation.

[71]  G. Klintmalm,et al.  Activation of the plasma contact system and hemodynamic changes after graft revascularization in liver transplantation. , 1995, Transplantation.

[72]  O. Stenqvist,et al.  COMPLEMENT SYSTEM ACTIVATION DURING ORTHOTOPIC LIVER TRANSPLANTATION IN MAN: Indications of Peroperative Complement System Activation in the Gut , 1994, Transplantation.

[73]  S. Blanot,et al.  Circulating endotoxins during orthotopic liver transplantation and post-reperfusion syndrome , 1993, The Lancet.

[74]  M. Pinsky,et al.  Right Ventricular Function During Orthotopic Liver Transplantation , 1993, Anesthesia and analgesia.

[75]  P. Albaladéjo,et al.  The failure of venovenous bypass to prevent graft liver postreperfusion syndrome. , 1992, Transplantation.

[76]  M. Pinsky,et al.  Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. , 1987, Transplantation proceedings.

[77]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[78]  S. M. Zhu,et al.  Epsilon-aminocaproic Acid Improves Postrecirculation Hemodynamics by Reducing Intraliver Activated Protein C Consumption in Orthotopic Liver Transplantation , 2013, World Journal of Surgery.

[79]  E. Bernardi,et al.  Hyperdynamic circulation in cirrhosis: predictive factors and outcome following liver transplantation. , 2013, Minerva anestesiologica.

[80]  R. Jiménez Paneque,et al.  Rapid and homogeneous reperfusion as a risk factor for postreperfusion syndrome during orthotopic liver transplantation. , 2010, Revista brasileira de anestesiologia.

[81]  M. Adham,et al.  Hemodynamic profiles during piggyback liver grafts using arterial or portal revascularization. , 2000, Journal of the American College of Surgeons.